Skip to content
Perdaman logo — We aim to be innovative, dynamic, evolving and at the forefr...

Perdaman

We aim to be innovative, dynamic, evolving and at the forefront of business. We want to help the world be better.

Founded 2006 Australia Australia 28 employees Private Equity Total: $2.37B Pharmaceutical

General Information

Company Name Perdaman
Founded Year 2006
Location Australia Australia
Employees 28
Industries Pharmaceutical
Funding Stage Private Equity
Business Model B2B, B2C, B2B2C
Revenue Model Product Sales, Service Fee, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with Perdaman. To contact Perdaman, visit perdaman.com.au.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Perdaman compare?

A PDF of Perdaman and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Perdaman soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Perdaman

Perdaman, founded in 2006 and headquartered in Australia, is a multinational enterprise recognized for its diversified market involvement, prominently within the Pharmaceutical industry. Despite its singular industrial classification, the company's expansive operations encompass investments in fertiliser production, the management of shopping centers, pharmaceutical distribution, migration services, and advanced energy solutions. These multifaceted ventures align with their slogan, "We aim to be innovative, dynamic, evolving and at the forefront of business. We want to help the world be better."

The company recently captured investor attention with a substantial $2.10 billion Private Equity Round investment on 20 April 2023, led by Global Infrastructure Partners. This investment signifies strong confidence in Perdaman's capacity to innovate and expand across diverse market sectors, potentially presenting considerable growth opportunities for prospective investors.

Business keywords: multinational group, diverse markets, investments, fertilizer production, shopping centers, pharmaceuticals, migration services, energy solutions, innovation, dynamic, evolving, Western Australia

Services & Products

Sustainable energy solutions
Fertilisers production
Pharmaceutical manufacturing
Financial and investment management
Recruitment and immigration services
Property development and management

Target Customers

Farmers Businesses seeking renewable energy solutions Companies requiring recruitment and immigration services Investors Healthcare providers Local communities for property and economic development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $269.00M 2
Export Finance Australia, Northern Australia Infrastructure Facility(NAIF)
20 Apr 2023
Private Equity Round $2.10B 1
Global Infrastructure Partners
20 Apr 2023

Perdaman Alternatives & Competitors

View All Alternatives
Perdaman vs

Servicio y trabajo con visión empresarial

28 employees
Finance, Pharmaceutical
Perdaman vs

Serving Sterile Health

394 employees
Manufacturing, Pharmaceutical
Perdaman vs

There is only one reason why we exist — to treat diseases, to heal and enrich human life.

Post-IPO Equity
5087 employees
Biotechnology, Manufacturing

FAQ About Perdaman

We aim to be innovative, dynamic, evolving and at the forefront of business. We want to help the world be better.
Perdaman was founded in 2006.
Perdaman is headquartered in Australia.
Perdaman operates in Pharmaceutical. Its work centres on multinational group, diverse markets, investments and fertilizer production. Its customers include Farmers, Businesses seeking renewable energy solutions and Companies requiring recruitment and immigration services.
Perdaman has a B2B, B2C and B2B2C business model. Its revenue comes from Product Sales, Service Fee and Consulting Fee.
Perdaman has approximately 28 employees.
Perdaman has completed 2 funding rounds, raising a total of $2.37B. The latest funding stage is Private Equity.
Perdaman offers: Sustainable energy solutions, Fertilisers production, Pharmaceutical manufacturing, Financial and investment management, Recruitment and immigration services, Property development and management.
Top alternatives and competitors to Perdaman include Grupo Maremi, Birgi Mefar Group, Lupin Pharmaceuticals, Batterjee Pharma, YSB Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Perdaman and Grupo Maremi are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Perdaman, https://bouncewatch.com/company/perdaman, updated 11 December 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout